Developer docs
API playgroundTry for free, no card

Search company profiles

BioElectronics

Full company profile

uuid003eamr

Namestring
BioElectronics
Legal namestring
BioElectronics Corporation
Websiteurl
bielcorp.com
Company typeenum
Public
Founded yearint
2000
Descriptiontext

BioElectronics Corporation is a Frederick, Maryland-based medical device developer founded in 2000 that designs, manufactures, and distributes non-invasive bioelectroceutical devices for pain management and wound healing. The company's core technology is Pulsed Shortwave Therapy (PSWT) / Pulsed Electromagnetic Field (PEMF) operating at 27.1 MHz, delivered through a small wearable adhesive device with a flexible antenna that emits less than 1 milliwatt of power to provide up to 720 hours of continuous home therapy. The technology is protected by US Patent No. 8,412,328, WIPO publication WO2013059804, a South Korean patent allowance, and a portfolio of 9 granted plus 8 pending international patents.

The company's product portfolio includes ActiPatch Therapy (OTC musculoskeletal pain relief at ~$30 retail), RecoveryRx (postoperative and chronic wound care distributed to healthcare professionals), Allay Menstrual Pain Therapy, Smart Insole for heel pain/plantar fasciitis, and veterinary products (HealFast, PetPatch Loop). BioElectronics sells through a dual-channel model: consumer OTC via retail pharmacy chains (Boots, Superdrug, Lloyds, Costco, Showcase), Amazon, and a Facebook "Try It and Tell Us" sampling program achieving approximately 70% sample-to-purchase conversion; and professional medical via enterprise distributors including B. Braun Medical (UK orthopaedics exclusive), D.E.N. Medical (Benelux), and Gro-International (400,000+ professional pharmacies across Europe and Africa), plus regional exclusive distributors in 20+ countries. CE Mark (November 2020) enables access to 33+ countries; Cofepris clearance enables Mexico launch (March 2022).

The company is publicly traded on OTC Pink Sheets under ticker BIEL after voluntarily terminating SEC registration in April 2011. Major convertible debt is held by Ibex LLC and St. John's LLC, both controlled by Whelan family members who have agreed to forgo interest for three consecutive years. Leadership includes Chairman Richard Staelin, Ph.D. (Duke Fuqua professor), President Andrew J. Whelan, EVP Dr. Deepak Kotak (Oxford-trained clinician), and a Medical Advisory Board headed by Dr. Lawrence L. Michaelis (Emeritus Professor of Surgery, Northwestern). The company has been recognized with multiple OTC Marketing Awards (2013-2014) for product innovation and packaging design.

Short descriptiontext

BioElectronics Corporation develops and markets non-invasive bioelectroceutical medical devices using Pulsed Electromagnetic Field technology for drug-free pain management, serving consumers with chronic musculoskeletal pain via retail pharmacies and healthcare professionals through medical distributors across 20+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersFrederick, United States
HQ citystring
Frederick
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pulsed electromagnetic therapy, medical device manufacturer, pain management devices, postoperative wound care, bioelectroceutical devices
Industry1 code
1Posture, Musculoskeletal & Pain-Relief Devices (Posture Trainers, TENS/EMS, Massage Devices)
CodeCRACAQAKPrimaryYes
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Surgical Appliance and Supplies Manufacturing339113
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
Product category
Medical Devices - Pain Management and Wound Healing
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Device Sales (Consumer OTC)
TypeOne Time License
Description

Sale of wearable medical devices directly to consumers through retail pharmacy chains (Boots, Superdrug, Lloyds, Costco) and online marketplaces. Revenue from ActiPatch, Allay, Smart Insole, and PetPatch products sold at retail price points ranging from $29-$30.

bielcorp.com
2Device Sales (Professional Medical)
TypeOne Time License
Description

Sale of RecoveryRx and ActiPatch devices through medical distributors and healthcare professionals for postoperative care, wound care, and orthopaedic applications. Includes B. Braun Medical in UK orthopaedics and D.E.N. Medical in Benelux.

bielcorp.com
3International Distribution Revenue
TypeOne Time License
Description

Revenue generated through exclusive and non-exclusive distribution agreements in international markets including Spain, Mexico, Korea, Czech Republic, Italy, Austria, Ireland, Turkey, Philippines, Iraq, Peru, Malaysia, Venezuela, Malta, Balkans, Canada, and others.

bielcorp.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels9 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Personnel, Marketing or Sales, Operations, Technology or R&D
Pricing details3 tiers
1ActiPatch Musculoskeletal Pain Therapy - Retail consumer pricing
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Approximately $30.00 retail price, providing 720 hours (30 days) of continuous therapy, equating to approximately $0.04 per hour of therapy. Sold at Boots UK for £19.99.

bielcorp.com
2ActiPatch 7-Day Sample Program - Consumer trial
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

7-day sample device provided free through the 'Try It and Tell Us' social media program for UK and Ireland residents.

bielcorp.com
3PetPatch Loop - Veterinary Pain Relief
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Fourth generation drug-free anti-inflammatory device for pets and horses, priced at $29.99.

bielcorp.com
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 6 records shown
1ActiPatch
Description

Over-the-counter pulsed shortwave therapy device for musculoskeletal pain relief including back, knee, elbow pain and osteoarthritis.

bielcorp.com
+5 more records
Core offering1 text field

BioElectronics Corporation develops, manufactures, and sells disposable, drug-free bioelectroceutical medical devices based on its patented Pulsed Shortwave Therapy (PSWT) / Pulsed Electromagnetic Field (PEMF) technology. The portfolio addresses chronic musculoskeletal pain (ActiPatch), postoperative and wound care (RecoveryRx), menstrual pain (Allay), heel pain (Smart Insole), and veterinary pain (PetPatch/HealFast), sold through retail pharmacies, online marketplaces, and medical distributors in more than 30 countries.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 11 values shown
  • 57% average pain reduction for 65% of ActiPatch users across multiple chronic pain conditions
+10 more records
Product overview1 text field

BioElectronics Corporation offers a portfolio of disposable, drug-free bioelectroceutical medical devices for pain management and wound healing. The core products include ActiPatch Therapy (over-the-counter musculoskeletal pain relief), RecoveryRx (postoperative and wound care), Allay Menstrual Pain Therapy, and HealFast Therapy (veterinary applications). The Smart Insole provides heel pain relief through Electro-Pulse technology, and PetPatch Loop extends the technology for veterinary use. All products utilize the company's patented pulsed shortwave/pulsed electromagnetic field technology to reduce pain and inflammation and accelerate healing.

Product and service6 records
1ActiPatch Therapy
CategoryMusculoskeletal Pain Therapy (OTC)
Description

Over-the-counter pulsed shortwave therapy device for musculoskeletal pain relief, providing 720 hours of continuous treatment for back, knee, elbow and other musculoskeletal complaints. Retail priced at approximately $30 (£19.99 at Boots UK).

2RecoveryRx
CategoryPostoperative and Wound Care Therapy
Description

Postoperative and wound care therapy device that reduces pain, inflammation and accelerates healing through bioelectroceutical technology. Distributed through medical channels including B. Braun Medical Ltd in UK orthopaedics and D.E.N. Medical in Benelux.

3Allay Menstrual Pain Therapy
CategoryMenstrual Pain Therapy (OTC)
Description

Over-the-counter menstrual cycle pain therapy device providing drug-free relief for menstrual cramping, bloating, and sore breasts.

4HealFast Therapy
CategoryVeterinary Pain Therapy
Description

Bioelectroceutical therapy device for dogs, cats and horses providing drug-free pain relief and healing.

5Smart Insole Heel Pain Therapy
CategoryHeel Pain Therapy (OTC)
Description

Combination of advanced Electro-Pulse technology and comfortable gel insoles clinically proven to safely reduce heel pain from plantar fasciitis.

6PetPatch Loop
CategoryVeterinary Pain Therapy
Description

Fourth generation drug-free anti-inflammatory medical device for use on pets and horses, priced at $29.99.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers8 records
TypeBroad incumbent
Description

Omron Healthcare is a large consumer-health brand selling TENS and electrotherapy pain-management devices globally through retail pharmacies and its own channels. Comparable to BioElectronics in OTC pain-device product category and pharmacy-channel distribution, but with a much broader health-and-wellness portfolio and brand scale.

TypeBroad incumbent
Description

BTL Industries manufactures PEMF, shockwave, and high-intensity focused electromagnetic devices used in physiotherapy, orthopedics, and pain management. Comparable to BioElectronics because it operates in the same PEMF/electromagnetic-therapy technology class for musculoskeletal pain, but at significantly larger scale across professional aesthetics and rehab segments.

TypeDirect peer
Description

iTENS designs small, wearable, smartphone-controlled TENS units sold online and through retail pharmacies specifically as a drug-free pain-relief consumer device. Directly comparable to BioElectronics: same wearable OTC TENS-adjacent form factor, same retail-pharmacy and e-commerce distribution, and same consumer chronic-pain positioning.

TypeBroad incumbent
Description

DJO Global (now part of Enovis) is a major orthopedic and rehabilitation medical device company whose Chattanooga brand sells TENS, EMS, ultrasound, and other electrotherapy pain-management devices used by clinicians and sold OTC. Comparable to BioElectronics across product category (electrotherapy pain devices) and channel mix (clinical + consumer), but with vastly broader portfolio and distribution scale.

TypeDirect peer
Description

NeuroMetrix developed and markets Quell, a wearable over-the-counter neurostimulation device for chronic pain, using a similar wearable-adhesive form factor and direct-to-consumer channel strategy. Highly comparable to BioElectronics' ActiPatch in product type, regulatory pathway, OTC positioning and chronic-pain patient target market.

TypeDirect peer
Description

Mettler Electronics manufactures TENS, EMS, ultrasound, and shortwave diathermy devices used by physical therapists and clinics for pain management and rehabilitation. Directly comparable to BioElectronics in the underlying electrotherapy product category and in serving musculoskeletal/orthopedic pain indications, though focused primarily on professional channels rather than OTC.

TypeEmerging player
Description

Theranica developed Nerivio, a wearable neurostimulation device for acute migraine cleared by the FDA and sold via prescription and consumer channels. Adjacent comparable: same wearable-electroceutical category for non-drug pain relief, similar FDA De Novo clearance path, and overlapping consumer vs. clinical go-to-market approach as BioElectronics.

TypeDirect peer
Description

Zynex Medical designs and sells prescription-strength TENS, EMS, and neurostimulation devices for pain management through physicians and direct channels. Highly comparable to BioElectronics: both sell electrical-stimulation pain devices, target chronic and postoperative pain indications, and pursue a mix of OTC-consumer and professional/clinical channels.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

BioElectronics

Medical Devices - Pain Management and Wound Healingbielcorp.com

BioElectronics Corporation develops and markets non-invasive bioelectroceutical medical devices using Pulsed Electromagnetic Field technology for drug-free pain management, serving consumers with chronic musculoskeletal pain via retail pharmacies and healthcare professionals through medical distributors across 20+ countries.

What BioElectronics does

BioElectronics Corporation is a Frederick, Maryland-based medical device developer founded in 2000 that designs, manufactures, and distributes non-invasive bioelectroceutical devices for pain management and wound healing. The company's core technology is Pulsed Shortwave Therapy (PSWT) / Pulsed Electromagnetic Field (PEMF) operating at 27.1 MHz, delivered through a small wearable adhesive device with a flexible antenna that emits less than 1 milliwatt of power to provide up to 720 hours of continuous home therapy. The technology is protected by US Patent No. 8,412,328, WIPO publication WO2013059804, a South Korean patent allowance, and a portfolio of 9 granted plus 8 pending international patents.

The company's product portfolio includes ActiPatch Therapy (OTC musculoskeletal pain relief at ~$30 retail), RecoveryRx (postoperative and chronic wound care distributed to healthcare professionals), Allay Menstrual Pain Therapy, Smart Insole for heel pain/plantar fasciitis, and veterinary products (HealFast, PetPatch Loop). BioElectronics sells through a dual-channel model: consumer OTC via retail pharmacy chains (Boots, Superdrug, Lloyds, Costco, Showcase), Amazon, and a Facebook "Try It and Tell Us" sampling program achieving approximately 70% sample-to-purchase conversion; and professional medical via enterprise distributors including B. Braun Medical (UK orthopaedics exclusive), D.E.N. Medical (Benelux), and Gro-International (400,000+ professional pharmacies across Europe and Africa), plus regional exclusive distributors in 20+ countries. CE Mark (November 2020) enables access to 33+ countries; Cofepris clearance enables Mexico launch (March 2022).

The company is publicly traded on OTC Pink Sheets under ticker BIEL after voluntarily terminating SEC registration in April 2011. Major convertible debt is held by Ibex LLC and St. John's LLC, both controlled by Whelan family members who have agreed to forgo interest for three consecutive years. Leadership includes Chairman Richard Staelin, Ph.D. (Duke Fuqua professor), President Andrew J. Whelan, EVP Dr. Deepak Kotak (Oxford-trained clinician), and a Medical Advisory Board headed by Dr. Lawrence L. Michaelis (Emeritus Professor of Surgery, Northwestern). The company has been recognized with multiple OTC Marketing Awards (2013-2014) for product innovation and packaging design.

BioElectronics firmographics

Firmographics
Name
BioElectronics
Legal name
BioElectronics Corporation
Website
https://bielcorp.com
Company type
Public
Founded year
2000
Operating status
Operating
Headcount range
11–50 employees
Short description
BioElectronics Corporation develops and markets non-invasive bioelectroceutical medical devices using Pulsed Electromagnetic Field technology for drug-free pain management, serving consumers with chronic musculoskeletal pain via retail pharmacies and healthcare professionals through medical distributors across 20+ countries.
Ownership category
akta.pro rank

BioElectronics industry classification

Industry
Product category
Medical Devices - Pain Management and Wound Healing
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical Appliance and Supplies Manufacturing (339113)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
akta.pro primary industry
Posture, Musculoskeletal & Pain-Relief Devices (Posture Trainers, TENS/EMS, Massage Devices) (CRACAQAK)

Keywords

  • Pulsed electromagnetic therapy
  • Medical device manufacturer
  • Pain management devices
  • Postoperative wound care
  • Bioelectroceutical devices

Where BioElectronics is headquartered

Location

Headquarters

HQ city
Frederick
HQ country
United States
HQ region
North America

Offices1 record

Markets served

BioElectronics business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Marketing or Sales, Operations, Technology or R&D

Revenue model

  1. Device Sales (Consumer OTC): Sale of wearable medical devices directly to consumers through retail pharmacy chains (Boots, Superdrug, Lloyds, Costco) and online marketplaces. Revenue from ActiPatch, Allay, Smart Insole, and PetPatch products sold at retail price points ranging from $29-$30.
  2. Device Sales (Professional Medical): Sale of RecoveryRx and ActiPatch devices through medical distributors and healthcare professionals for postoperative care, wound care, and orthopaedic applications. Includes B. Braun Medical in UK orthopaedics and D.E.N. Medical in Benelux.
  3. International Distribution Revenue: Revenue generated through exclusive and non-exclusive distribution agreements in international markets including Spain, Mexico, Korea, Czech Republic, Italy, Austria, Ireland, Turkey, Philippines, Iraq, Peru, Malaysia, Venezuela, Malta, Balkans, Canada, and others.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goActiPatch Musculoskeletal Pain Therapy - Retail consumer pricing
One time/ perpetual licensePay-as-you-goActiPatch 7-Day Sample Program - Consumer trial
One time/ perpetual licensePay-as-you-goPetPatch Loop - Veterinary Pain Relief

Go-to-market motion2 records

Distribution channels9 records

Marketing channels6 records

BioElectronics product offering

Product offering

Core offering

BioElectronics Corporation develops, manufactures, and sells disposable, drug-free bioelectroceutical medical devices based on its patented Pulsed Shortwave Therapy (PSWT) / Pulsed Electromagnetic Field (PEMF) technology. The portfolio addresses chronic musculoskeletal pain (ActiPatch), postoperative and wound care (RecoveryRx), menstrual pain (Allay), heel pain (Smart Insole), and veterinary pain (PetPatch/HealFast), sold through retail pharmacies, online marketplaces, and medical distributors in more than 30 countries.

Product overview

BioElectronics Corporation offers a portfolio of disposable, drug-free bioelectroceutical medical devices for pain management and wound healing. The core products include ActiPatch Therapy (over-the-counter musculoskeletal pain relief), RecoveryRx (postoperative and wound care), Allay Menstrual Pain Therapy, and HealFast Therapy (veterinary applications). The Smart Insole provides heel pain relief through Electro-Pulse technology, and PetPatch Loop extends the technology for veterinary use. All products utilize the company's patented pulsed shortwave/pulsed electromagnetic field technology to reduce pain and inflammation and accelerate healing.

Differentiator

Problem solved

Functional benefit

Brands

  • ActiPatch: Over-the-counter pulsed shortwave therapy device for musculoskeletal pain relief including back, knee, elbow pain and osteoarthritis.
  • RecoveryRx
  • Allay
  • HealFast
  • Smart Insole
  • PetPatch

Products and services

  • ActiPatch Therapy Over-the-counter pulsed shortwave therapy device for musculoskeletal pain relief, providing 720 hours of continuous treatment for back, knee, elbow and other musculoskeletal complaints. Retail priced at approximately $30 (£19.99 at Boots UK).
  • RecoveryRx Postoperative and wound care therapy device that reduces pain, inflammation and accelerates healing through bioelectroceutical technology. Distributed through medical channels including B. Braun Medical Ltd in UK orthopaedics and D.E.N. Medical in Benelux.
  • Allay Menstrual Pain Therapy Over-the-counter menstrual cycle pain therapy device providing drug-free relief for menstrual cramping, bloating, and sore breasts.
  • HealFast Therapy Bioelectroceutical therapy device for dogs, cats and horses providing drug-free pain relief and healing.
  • Smart Insole Heel Pain Therapy Combination of advanced Electro-Pulse technology and comfortable gel insoles clinically proven to safely reduce heel pain from plantar fasciitis.
  • PetPatch Loop Fourth generation drug-free anti-inflammatory medical device for use on pets and horses, priced at $29.99.

Quantifiable outcome

  • 57% average pain reduction for 65% of ActiPatch users across multiple chronic pain conditions
  • +10 more outcomes

Companies that use BioElectronics

Customer profile

Named customers3 records

Segments6 records

Ideal customer profiles5 records

BioElectronics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

BioElectronics partnerships and signals

Strategic signal

Scale indicators10 records

Recent moves7 records

Expansion highlights6 records

BioElectronics competitors and assessment

Company assessment

Broad incumbents

  • Omron Healthcare: Omron Healthcare is a large consumer-health brand selling TENS and electrotherapy pain-management devices globally through retail pharmacies and its own channels. Comparable to BioElectronics in OTC pain-device product category and pharmacy-channel distribution, but with a much broader health-and-wellness portfolio and brand scale.
  • BTL Industries: BTL Industries manufactures PEMF, shockwave, and high-intensity focused electromagnetic devices used in physiotherapy, orthopedics, and pain management. Comparable to BioElectronics because it operates in the same PEMF/electromagnetic-therapy technology class for musculoskeletal pain, but at significantly larger scale across professional aesthetics and rehab segments.
  • DJO Global (Enovis): DJO Global (now part of Enovis) is a major orthopedic and rehabilitation medical device company whose Chattanooga brand sells TENS, EMS, ultrasound, and other electrotherapy pain-management devices used by clinicians and sold OTC. Comparable to BioElectronics across product category (electrotherapy pain devices) and channel mix (clinical + consumer), but with vastly broader portfolio and distribution scale.

Direct peers

  • iTENS: iTENS designs small, wearable, smartphone-controlled TENS units sold online and through retail pharmacies specifically as a drug-free pain-relief consumer device. Directly comparable to BioElectronics: same wearable OTC TENS-adjacent form factor, same retail-pharmacy and e-commerce distribution, and same consumer chronic-pain positioning.
  • NeuroMetrix: NeuroMetrix developed and markets Quell, a wearable over-the-counter neurostimulation device for chronic pain, using a similar wearable-adhesive form factor and direct-to-consumer channel strategy. Highly comparable to BioElectronics' ActiPatch in product type, regulatory pathway, OTC positioning and chronic-pain patient target market.
  • Mettler Electronics: Mettler Electronics manufactures TENS, EMS, ultrasound, and shortwave diathermy devices used by physical therapists and clinics for pain management and rehabilitation. Directly comparable to BioElectronics in the underlying electrotherapy product category and in serving musculoskeletal/orthopedic pain indications, though focused primarily on professional channels rather than OTC.
  • Zynex Medical: Zynex Medical designs and sells prescription-strength TENS, EMS, and neurostimulation devices for pain management through physicians and direct channels. Highly comparable to BioElectronics: both sell electrical-stimulation pain devices, target chronic and postoperative pain indications, and pursue a mix of OTC-consumer and professional/clinical channels.

Emerging players

  • Theranica Bio-Electronics: Theranica developed Nerivio, a wearable neurostimulation device for acute migraine cleared by the FDA and sold via prescription and consumer channels. Adjacent comparable: same wearable-electroceutical category for non-drug pain relief, similar FDA De Novo clearance path, and overlapping consumer vs. clinical go-to-market approach as BioElectronics.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

BioElectronics social profiles

Digital presence

BioElectronics compliance and trust

Trust signal

Compliance3 records

BioElectronics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

BioElectronics leadership team

Management profile

Number of profiles

Profiles7 records

BioElectronics funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

BioElectronics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioElectronics

What does BioElectronics do?

BioElectronics Corporation develops, manufactures, and sells disposable, drug-free bioelectroceutical medical devices based on its patented Pulsed Shortwave Therapy (PSWT) / Pulsed Electromagnetic Field (PEMF) technology. The portfolio addresses chronic musculoskeletal pain (ActiPatch), postoperative and wound care (RecoveryRx), menstrual pain (Allay), heel pain (Smart Insole), and veterinary pain (PetPatch/HealFast), sold through retail pharmacies, online marketplaces, and medical distributors in more than 30 countries.

Is BioElectronics a public or private company?

BioElectronics is a public company. It is classified as public and is currently operating.

When was BioElectronics founded?

BioElectronics was founded in 2000. It employs 11 to 50 people.

Where is BioElectronics based?

BioElectronics is headquartered in Frederick, United States, in the North America region.

How does BioElectronics make money?

Three revenue lines are on record. Device Sales (Consumer OTC) is the primary driver. The others are device Sales (Professional Medical) and international Distribution Revenue.

Who are BioElectronics's main competitors?

Broad incumbents on record are Omron Healthcare, BTL Industries and DJO Global (Enovis). Direct peers are iTENS, NeuroMetrix, Mettler Electronics and Zynex Medical. Theranica Bio-Electronics is listed as an emerging player.

Does BioElectronics have an API?

No public API is recorded for BioElectronics.

What industry is BioElectronics in?

BioElectronics's product category is Medical Devices - Pain Management and Wound Healing. Its primary akta.pro industry code is CRACAQAK, Posture, Musculoskeletal & Pain-Relief Devices (Posture Trainers, TENS/EMS, Massage Devices). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
InvestorshangoutTaking the opportunity to expand - BIEL BioElectronics CorporationAn investor-grade synthesis reports that Electrome and BIEL BioElectronics have moved from narrative to commercial execution, with ActiPatch manufacturing underway under Electrome's PAINKILLER platform and VA deployments already begun. The analysis cites a planned retail rollout of roughly 3,700 pharmacies in Q3 2026, plus DTC, veterinary, international and AI/data monetization vectors. Stock rose 33% on partnership news in March 2026.InvestorshangoutFollowing is a summary of my conversation - BIEL BioElectronics CorporationA stock research post outlines bullish evidence for BioElectronics Corporation (BIEL) as it moves from announcements toward operational preparation and actual commercialization. The author says the decisive evidence remains a September launch, customer sales, repeat orders and rising revenue. The most bullish scenario involves Electrome commercializing BIEL's ActiPatch technology, building an AI layer and distribution channels, generating cash and reinvesting.InvestorshangoutCEO Kelly posted on Biel shareholder - BIEL BioElectronics CorporationBioElectronics Corporation is shifting its strategic focus toward expanding the promotion of its RecoveryRx and RecoveryRx Veterinary products after Electrome assumed responsibility for ActiPatch sales. The company will sponsor and exhibit RecoveryRx at an upcoming AANA/BA Orthobiologics Ultrasound Lab Course in Illinois to introduce the device to medical professionals as a drug-free alternative for pain management.NewMediaWireBioElectronics Corporation Doubles Facility Space to Support Electrome's Commercial ActiPatch Launch and Anticipated Sales GrowthBioElectronics Corporation is expanding its facility to support Electrome's direct-to-consumer launch of ActiPatch, a drug-free pain relief product. The expansion includes dedicated fulfillment capacity for ActiPatch and anticipated RecoveryRx orders, with BioElectronics providing storage, packing, and shipping services. The arrangement also creates additional service-based revenue opportunities.FinancialContent Business PageBioElectronics Corporation Doubles Facility Space to Support Electrome's Commercial ActiPatch Launch and Anticipated Sales GrowthBioElectronics Corporation has doubled its facility space following the execution of a Fulfillment Services and Distribution Control Agreement with Electrome Corporation, establishing a new fulfillment center to support Electrome's planned direct-to-consumer launch of ActiPatch in newly designed branded packaging. Under the agreement, BioElectronics will provide inventory receiving, storage, order processing, packing, shipping coordination, and returns-management services, receiving monthly storage fees, pick-and-pack fees, and additional charges for various fulfillment activities. The expanded facility is also expected to support anticipated increased demand for RecoveryRx, BioElectronics' FDA-cleared prescription medical device for pain management, creating an additional service-based revenue opportunity alongside product sales.InvestorshangoutTomorrows PR Before The Market - BIEL BioElectronics CorporationBioElectronics Corporation has expanded its Maryland headquarters by leasing an adjacent office suite to operate as a dedicated storage and fulfillment center supporting new commercial activity involving ActiPatch and RecoveryRx products. The expansion follows a Fulfillment Services and Distribution Control Agreement with Electrome Corporation, under which BioElectronics will provide inventory receiving, storage, order processing, packing, shipping coordination, and returns-management services. The agreement provides BioElectronics with monthly storage fees, order-based pick-and-pack fees, and additional service fees, creating a new service-based revenue stream alongside product sales.InvestorshangoutInteresting response to Bobby's - BIEL BioElectronics CorporationThe article contains a series of news snippets and forum discussions largely unrelated to a single event. It mentions BioElectronics Corporation responding to a market maker question and covers various unrelated news topics such as 5G, gene therapy, data breaches, and stock movements.InvestorshangoutThis manufacturing setup directly - BIEL BioElectronics CorporationA stock message board post discusses BioElectronics Corporation's (BIEL) strategic decision to transition manufacturing from China to a domestic compliant partner like Viant Medical to avoid tariffs and supply chain vulnerabilities. The move also enables BIEL to secure U.S. government contracts by satisfying domestic sourcing requirements under the Buy American Act and Trade Agreements Act, with the company reportedly earning approximately 87% margins on existing VA sales.InvestorshangoutBIEL = GOAT NOW IMMINENT! BIEL - BIEL BioElectronics CorporationBioElectronics Corporation (BIEL) announced that its partner Electrome has placed its first major commercial order for 100,000 units at an estimated $15 net profit per unit, generating $1.5 million in profit for BIEL's bottom line. The company, operating as a lean 4-employee operation with a reported small profit in 2025 from baseline revenue of $500K, states this single order accelerates its path toward stock price milestones, positioning it closer to a $0.10 price-per-share target that would represent over 100,000% appreciation from its all-time low. The partnership was confirmed active in the June 30, 2026 Chairman's Update, with BIEL also holding a $41 million tax-loss carryforward to offset future profits.InvestorshangoutElectrome 100,000 Unit Order Impact: ​1. - BIEL BioElectronics CorporationThis is a speculative investor analysis post on a stock message board discussing how a hypothetical 100,000-unit Electrome order could impact BioElectronics Corporation (BIEL) financially and its stock price, with the author projecting the order could generate $2.0M in gross revenue and help the company reach various profit milestones toward a potential $0.10 stock valuation by 2028.